Dynavax Technologies Corp...

NASDAQ: DVAX · Real-Time Price · USD
10.70
0.08 (0.75%)
At close: Aug 15, 2025, 12:19 PM

Dynavax Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
95.88M 150.28M 202M 436.19M
Short-Term Investments
617.95M 592.02M 422.39M 109.76M
Long-Term Investments
n/a 277K 207K 219K
Other Long-Term Assets
74.76M 74.05M 236.66M 368.85M
Receivables
46.91M 44.53M 147.51M 131.82M
Inventory
70.05M 53.29M 59.45M 61.34M
Other Current Assets
18.15M 19M 85.63M 73.76M
Total Current Assets
848.94M 859.12M 916.99M 972.52M
Property-Plant & Equipment
60.61M 61.58M 63.34M 60.98M
Goodwill & Intangibles
1.95M 2.07M 2.01M 2.13M
Total Long-Term Assets
137.31M 137.98M 302.01M 431.96M
Total Assets
986.26M 997.1M 985.85M 1.04B
Account Payables
9.06M 5.25M 3.21M 2.6M
Deferred Revenue
n/a n/a n/a 349.86M
Short-Term Debt
4.17M 4.5M 3.63M 2.58M
Other Current Liabilities
22K 30.89M -3.63M 15.45M
Total Current Liabilities
78.63M 62.2M 150.07M 556.4M
Long-Term Debt
223.85M 222.7M 221.58M 220.49M
Other Long-Term Liabilities
60.58M 60.41M 384K 5.66M
Total Long-Term Liabilities
310.82M 312.83M 254.76M 260.47M
Total Liabilities
389.46M 375.02M 404.84M 816.87M
Total Debt
254.42M 256.91M 258.01M 257.38M
Common Stock
125K 130K 128K 123K
Retained Earnings
-903.27M -930.58M -924.2M -1.22B
Comprehensive Income
-4.72M -2.11M -5.44M -2.27M
Shareholders Equity
596.8M 622.07M 581.01M 222.37M
Total Investments
617.95M 592.02M 422.39M 109.76M